Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

MGP van der Wijst, SE Vazquez… - Science translational …, 2021 - science.org
Neutralizing autoantibodies against type I interferons (IFNs) have been found in some
patients with critical coronavirus disease 2019 (COVID-19), the disease caused by severe …
被引用次数：181 相关文章

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

MGP van der Wijst, SE Vazquez… - Science …, 2021 - pubmed.ncbi.nlm.nih.gov
Neutralizing autoantibodies against type I interferons (IFNs) have been found in some
patients with critical coronavirus disease 2019 (COVID-19), the disease caused by severe …
[HTML] nih.gov

[HTML][HTML] Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

MGP van der Wijst, SE Vazquez… - Science Translational …, 2021 - ncbi.nlm.nih.gov
Neutralizing autoantibodies against type I interferons (IFNs) have been found in some
patients with critical coronavirus disease 2019 (COVID-19), the disease caused by severe …

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

MGP van der Wijst, SE Vazquez… - Science Translational …, 2021 - escholarship.org
Neutralizing autoantibodies against type I interferons (IFNs) have been found in some
patients with critical coronavirus disease 2019 (COVID-19), the disease caused by severe …

[引用][C] Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

MGP van der Wijst, SE Vazquez… - Science Translational …, 2021 - cir.nii.ac.jp
Type I interferon autoantibodies are associated with systemic immune alterations in patients
with COVID-19 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

MGP van der Wijst, SE Vazquez… - Science Translational …, 2021 - research.rug.nl
Neutralizing autoantibodies against type I interferons (IFNs) have been found in some
patients with critical coronavirus disease 2019 (COVID-19), the disease caused by severe …

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.

MGP van der Wijst, SE Vazquez… - Science …, 2021 - search.ebscohost.com
Interfering with interferons: A subset of patients diagnosed with coronavirus disease 2019
(COVID-19) present with autoantibodies specific to type I interferons (IFNs). However, the …

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.

MGP van der Wijst, SE Vazquez… - Science Translational …, 2021 - europepmc.org
Neutralizing autoantibodies against type I interferons (IFNs) have been found in some
patients with critical coronavirus disease 2019 (COVID-19), the disease caused by severe …
[HTML] nih.gov

[HTML][HTML] Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

MGP van der Wijst, SE Vazquez… - Science translational …, 2021 - ncbi.nlm.nih.gov
Neutralizing autoantibodies against type I interferons (IFNs) have been found in some
patients with critical coronavirus disease 2019 (COVID-19), the disease caused by severe …

[引用][C] Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

MGP van Wijst - Sci Transl Med, 2021 - cir.nii.ac.jp
Type I interferon autoantibodies are associated with systemic immune alterations in patients
with COVID-19 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …